checkAd
    Startseite > Aktien > MeiraGTx Holdings > Nachrichten
    MeiraGTx Holdings Aktie
    4,4400
     
    EUR
    -0,89 %
    -0,0400 EUR
    Letzter Kurs 25.04.24 Frankfurt
    4,3200
     
    EUR
    700 STK
    Geldkurs 25.04.24
    4,4600
     
    EUR
    700 STK
    Briefkurs 25.04.24
    ISIN: KYG596651029 · WKN: A2JGHF · SYM: 328 · Kaiman-Inseln

    Neueste Nachrichten

    MeiraGTx to Participate in Upcoming Investor Conferences
    24.04.24 · globenewswire · MeiraGTx Holdings
    MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
    18.04.24 · globenewswire · MeiraGTx Holdings
    MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
    14.03.24 · globenewswire · MeiraGTx Holdings
    MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
    13.02.24 · globenewswire · MeiraGTx Holdings
    MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
    21.12.23 · globenewswire · MeiraGTx Holdings
    MeiraGTx to Participate in Upcoming Investor Conferences
    21.11.23 · globenewswire · MeiraGTx Holdings
    MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
    14.11.23 · globenewswire · MeiraGTx Holdings
    MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities
    30.10.23 · globenewswire · MeiraGTx Holdings
    MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress
    24.10.23 · globenewswire · MeiraGTx Holdings
    MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
    10.08.23 · globenewswire · MeiraGTx Holdings
    MeiraGTx Announces Poster Presentation at the 2023 American Society of Gene and Cell Therapy (ASGCT) Spotlight on Immuno-Oncology
    01.08.23 · globenewswire · MeiraGTx Holdings
    MeiraGTx Announces its Wholly-Owned Gene Therapy Manufacturing Facility in Shannon, Ireland has Received Commercial MIA Authorization for QC Testing
    19.07.23 · globenewswire · MeiraGTx Holdings